Evaluation of Moderate to Severe Influenza Outcomes in Children

CompletedOBSERVATIONAL
Enrollment

1,478

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

May 4, 2018

Study Completion Date

May 5, 2018

Conditions
InfluenzaOtitis MediaLower Resp Tract InfectionEncephalitic InfectionMyositis ViralFever
Interventions
PROCEDURE

Respiratory nasal swab

Nasal swabs will be obtained for testing by the study nurses. If a respiratory sample has already been collected as part of routine clinical care, this will replace the study collection, and no additional testing will be required.

Trial Locations (2)

80023

Children's Hospital North Campus Urgent Care, Broomfield

80045

Children's Hospital Colorado, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Colorado, Denver

OTHER